NHS Greater Glasgow & Clyde Area Drug and Therapeutics Committee
Greater Glasgow and Clyde Medicines
Greater Glasgow and Clyde Medicines
For all prescribers and health professionals both in primary care and the acute sector.
All editions of PostScript (the previous name for Medicines Update) from 2011 onwards have been added to this site. Click here for an index to all previous editions. If you would like a copy of a previous edition, please contact medicines.update@ggc.scot.nhs.uk
Posted: December 17, 2018.
Category - Medicines Update
To aid medicines reconciliation/supply for care home patients in acute care
Posted: December 17, 2018.
Category - Medicines Update
Launch of the two new “triple inhalers” described below has presented an opportunity to simplify inhaler regimens for some patients with COPD, while simultaneously generating substantial efficiency savings. Note that Trimbow...
Posted: December 11, 2018.
Category - Medicines Update
GP Practices and Community Pharmacies can now order printed copies of the new Direct Oral Anticoagulant (DOAC) Patient Information Booklet and Alert Card. Printed copies remain available for use in hospitals across NHSGGC. Please refer to this ...
Posted: December 05, 2018.
Category - Medicines Update
Updated Adult NHSGGC Guidelines now available on Staffnet Sign Guidelines <...
Posted: November 28, 2018.
Category - Medicines Update
Drug Safety Update (October 2018) includes: Rivaroxaban (Xarelto▼)
Posted: November 19, 2018.
Category - Medicines Update
Yellow Card Scotland has provided a summary of the importance and relevance to practice of reporting adverse drug reactions (ADRs) via the Yellow Card scheme. KEY POINTS As little as 2 or 3 reports of an ...
Posted: November 03, 2018.
Category - Medicines Update
The Adult Therapeutics Handbook content has now been updated and includes the following main changes: Respiratory System The
Posted: October 30, 2018.
Category - Medicines Update
A Direct Oral Anticoagulant (DOAC) Patient Information Booklet and Alert Card have been developed for use across NHSGGC. This new resource is suitable for patients taking apixaban, dabigatran, edoxaban or rivaroxaban and highlights key ...
Posted: October 29, 2018.
Category - Medicines Update
Background A previous blog Drug Safety Information: valproate medicines highlighted the MHRA valproate medicines safety alert April 2018 regarding women taking valproate medicines. This article gives local expert advice...
Posted: October 10, 2018.
Category - Medicines Update
Key messages Constipation is a very common adverse effect of clozapine treatmentMortality rates associated with complications from clozapine-induced constipation are higher than the risk of fatal agranulocytosisThe risk o...